
SEVERE HEPATOTOXICITY SECONDARY TO NINTEDANIB
Author(s) -
M Librero Jiménez,
C Heredia Carrasco,
María Carmen Fernández Cano
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7585/2020
Subject(s) - medicine , nintedanib , intensive care medicine , lung , idiopathic pulmonary fibrosis
Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.